DE2724114A1 - Verfahren zum bestimmen von melanomata und anderen tumoren im menschen - Google Patents

Verfahren zum bestimmen von melanomata und anderen tumoren im menschen

Info

Publication number
DE2724114A1
DE2724114A1 DE19772724114 DE2724114A DE2724114A1 DE 2724114 A1 DE2724114 A1 DE 2724114A1 DE 19772724114 DE19772724114 DE 19772724114 DE 2724114 A DE2724114 A DE 2724114A DE 2724114 A1 DE2724114 A1 DE 2724114A1
Authority
DE
Germany
Prior art keywords
cancer
malignant
tumor
extract
detected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19772724114
Other languages
German (de)
English (en)
Inventor
Jose Ramon Marti
David Marshall Parks Thomson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE2724114A1 publication Critical patent/DE2724114A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE19772724114 1976-05-27 1977-05-27 Verfahren zum bestimmen von melanomata und anderen tumoren im menschen Withdrawn DE2724114A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69045476A 1976-05-27 1976-05-27

Publications (1)

Publication Number Publication Date
DE2724114A1 true DE2724114A1 (de) 1977-12-15

Family

ID=24772522

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772724114 Withdrawn DE2724114A1 (de) 1976-05-27 1977-05-27 Verfahren zum bestimmen von melanomata und anderen tumoren im menschen

Country Status (18)

Country Link
JP (1) JPS52145517A (sv)
AT (1) AT357690B (sv)
AU (1) AU506539B2 (sv)
BE (1) BE855063A (sv)
DE (1) DE2724114A1 (sv)
DK (1) DK233277A (sv)
ES (1) ES459164A1 (sv)
FI (1) FI771646A (sv)
FR (1) FR2352533A1 (sv)
GB (1) GB1520208A (sv)
IE (1) IE45284B1 (sv)
IL (1) IL52133A0 (sv)
LU (1) LU77413A1 (sv)
NL (1) NL7705873A (sv)
NO (1) NO771860L (sv)
NZ (1) NZ184159A (sv)
SE (1) SE7706203L (sv)
ZA (1) ZA773026B (sv)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3999944A (en) * 1975-02-28 1976-12-28 Hoffmann-La Roche Inc. Detection of breast cancer
US4043757A (en) * 1975-05-20 1977-08-23 Ortho Pharmaceutical Corporation Method for detection of human mammary carcinoma

Also Published As

Publication number Publication date
NZ184159A (en) 1979-03-28
ES459164A1 (es) 1978-04-16
NO771860L (no) 1977-11-29
JPS52145517A (en) 1977-12-03
AU2534177A (en) 1978-11-23
IE45284L (en) 1977-11-27
FR2352533A1 (fr) 1977-12-23
BE855063A (fr) 1977-11-28
IE45284B1 (en) 1982-07-28
AU506539B2 (en) 1980-01-10
IL52133A0 (en) 1977-07-31
ZA773026B (en) 1978-04-26
FI771646A (sv) 1977-11-28
NL7705873A (nl) 1977-11-29
GB1520208A (en) 1978-08-02
FR2352533B1 (sv) 1980-06-13
DK233277A (da) 1977-11-28
SE7706203L (sv) 1977-11-28
AT357690B (de) 1980-07-25
ATA376977A (de) 1979-12-15
LU77413A1 (sv) 1978-06-26

Similar Documents

Publication Publication Date Title
Bradley et al. Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice.
DE3779909T2 (de) In-vitro-testverfahren zum nachweis zellulaerer immunresponsen.
DE2806146C2 (de) Tumor-spezifisches Glykoprotein und dessen Verwendung zur Krebsdiagnose beim Menschen
Ottesen et al. Specific allergic sensitisation to filarial antigens in tropical eosinophilia syndrome
Ahlstedt et al. Specific IgE determination by RAST compared with skin and provocation tests in allergy diagnosis with birch pollen, timothy pollen and dog epithelium allergens
DD202178A5 (de) Verfahren und reagens zur untersuchung von antigen-antikoerper-reaktionen
Edozien et al. The relationship of serum gamma-globulin concentration to malaria and sickling
Brambell et al. The selective admission of antibodies to the foetus by the yolk-sac splanchnopleur in rabbits
CH631266A5 (de) Diagnostisches mittel.
MacKIE et al. Lymphocyte abnormalities in mycosis fungoides
DE3105555C2 (sv)
DE3030806A1 (de) Verfahren zur durchfuehrung von enzymimmunobestimmungen.
CH645726A5 (de) Praeparat zur bestimmung von menschlichem immunoglobulin g, verfahren zu seiner herstellung und seine verwendung.
DE2934756A1 (de) Zusammensetzung zur bestimmung von beta 2 -humanmikroglobulin und verfahren zu deren herstellung und deren verwendung
EP0011716B1 (de) Reagenz zum Nachweis von infektiöser Mononucleose und Verfahren zu seiner Herstellung
DE2724114A1 (de) Verfahren zum bestimmen von melanomata und anderen tumoren im menschen
Debbie et al. Some hematological values of free-ranging African elephants
Behbehani et al. Epidemiology of toxoplasmosis in Kuwait. I. Detection of antibodies to Toxoplasma gondii and percentage distribution among the inhabitants
DE2701643A1 (de) Verfahren zur extraktion von antigenen, deren verwendung und sie enthaltende produkte
Levine et al. Deficient resistance to Coccidioides immitis following intravenous vaccination: III. Humoral and cellular responses to intravenous and intramuscular doses
Caspary Precipitating antibody in multiple sclerosis and experimental allergic encephalomyelitis: Specific binding of radio-iodinated encephalitogenic factor
Runge et al. In vivo and in vitro responses to autologous IgG in patients with rheumatoid arthritis
Khan et al. The interactions of the erythrocytes of various species with agglutinins of Abrus precatorius Linn
Morizane et al. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay
EP0034301A2 (de) Verfahren zur Bestimmung von Immunkomplexen

Legal Events

Date Code Title Description
OB Request for examination as to novelty
OC Search report available
8139 Disposal/non-payment of the annual fee